United Therapeutics (UTHR) Crossed Above the 50-Day Moving Average: What That Means for Investors
Werte in diesem Artikel
From a technical perspective, United Therapeutics (UTHR) is looking like an interesting pick, as it just reached a key level of support. UTHR recently overtook the 50-day moving average, and this suggests a short-term bullish trend.The 50-day simple moving average, which is one of three major moving averages, is widely used by traders and analysts to establish support and resistance levels for a range of securities. Because it's the first sign of an up or down trend, the 50-day is considered to be more important.Shares of UTHR have been moving higher over the past four weeks, up 6.9%. Plus, the company is currently a Zacks Rank #3 (Hold) stock, suggesting that UTHR could be poised for a continued surge.The bullish case solidifies once investors consider UTHR's positive earnings estimate revisions. No estimate has gone lower in the past two months for the current fiscal year, compared to 2 higher, while the consensus estimate has increased too.Investors may want to watch UTHR for more gains in the near future given the company's key technical level and positive earnings estimate revisions.7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.5% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report United Therapeutics Corporation (UTHR): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: United Therapeutics und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf United Therapeutics
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf United Therapeutics
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu United Therapeutics Corp.
Analysen zu United Therapeutics Corp.
Datum | Rating | Analyst | |
---|---|---|---|
12.10.2018 | United Therapeutics Buy | Standpoint Research | |
22.02.2018 | United Therapeutics Underweight | Barclays Capital | |
27.12.2017 | United Therapeutics Outperform | Wedbush Morgan Securities Inc. | |
27.04.2017 | United Therapeutics Outperform | Wedbush Morgan Securities Inc. | |
30.03.2017 | United Therapeutics Sell | UBS AG |
Datum | Rating | Analyst | |
---|---|---|---|
12.10.2018 | United Therapeutics Buy | Standpoint Research | |
27.12.2017 | United Therapeutics Outperform | Wedbush Morgan Securities Inc. | |
27.04.2017 | United Therapeutics Outperform | Wedbush Morgan Securities Inc. | |
28.03.2016 | United Therapeutics Outperform | Wedbush Morgan Securities Inc. | |
02.03.2016 | United Therapeutics Outperform | Wedbush Morgan Securities Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
19.01.2017 | United Therapeutics Hold | Standpoint Research | |
15.06.2016 | United Therapeutics Neutral | H.C. Wainwright & Co. | |
11.04.2016 | United Therapeutics Sector Perform | RBC Capital Markets | |
29.07.2015 | United Therapeutics Sector Perform | RBC Capital Markets | |
29.04.2015 | United Therapeutics Sector Perform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
22.02.2018 | United Therapeutics Underweight | Barclays Capital | |
30.03.2017 | United Therapeutics Sell | UBS AG | |
12.08.2008 | United Therapeutics Ersteinschätzung | Piper Jaffray & Co. | |
03.05.2006 | United Therapeutics ausgestoppt | Der Aktionär |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für United Therapeutics Corp. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen